| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |